A detailed history of Vigilant Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 300 shares of CRSP stock, worth $14,379. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$14,379
Previous $14,000 21.43%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$39.19 - $65.67 $18,536 - $31,061
-473 Reduced 61.19%
300 $12,000
Q1 2021

Apr 16, 2021

BUY
$110.72 - $210.04 $52,370 - $99,348
473 Added 157.67%
773 $94,000
Q3 2020

Oct 15, 2020

BUY
$78.5 - $100.64 $23,550 - $30,192
300 New
300 $25,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.74B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Vigilant Capital Management, LLC Portfolio

Follow Vigilant Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.